LONG-TERM SURVEILLANCE STUDY OF RITUXIMAB (MABTHERA)-TREATED PATIENTS WITH GRANULOMATOSIS WITH POLYANGIITIS (GPA) OR MICROSCOPIC POLYANGIITIS (MPA) (RIVAS)

23/11/2016
14/03/2024
EU PAS number:
EUPAS16359
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

BE29950_RIVAS_Protocol_Amendment_MARC_Redacted

English (1.15 MB - PDF) View document
Updated protocol

RIVAS NIS Protocol Amendment v.2.3 25032020 clean_Redacted

First published: 22/02/2024
English (6.94 MB - PDF) View document
Study results
Study results

CSR_Synopsis_BE29950_(RIVAS)__Redacted

English (125.34 KB - PDF) View document
Study report
Study report

RIVAS_annual_report_2021_December_6_2021

English (1.57 MB - PDF) View document
Other information